Ultrasound diagnosed adenomyosis has a negative impact on successful implantation following GnRH antagonist IVF treatment

Human Reproduction

Volumn 27, Issue 12, 2012, Pages 3487-3492

  Thalluri, V ^a   Tremellen, K P ^b,c  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b Repromed   (Australia)

^c UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

adenomyosis; GnRH antagonist; implantation; in vitro fertilization; infertility

Indexed keywords

GANIRELIX;

ADENOMYOSIS; ADULT; ARTICLE; EMBRYO; EMBRYO TRANSFER; FEMALE; HUMAN; INFERTILITY THERAPY; MAJOR CLINICAL STUDY; MATERNAL AGE; OVULATION INDUCTION; PREGNANCY RATE; ULTRASOUND;

EID: 84870009572     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/des305     Document Type: Article

References (27)

1. Alfarawati S, Fragouli E, Colls P, Stevens J, Gutierrez-Mateo C, Schoolcraft WB, Katz-Jaffe MG, Wells D. The relationship between blastocyst morphology, chromosomal abnormality, and embryo gender. Fertil Steril 2011;95:520-524.
2. Ballester M, d'Argent EM, Morcel K, Belaisch-Allart J, Nisolle M, Daraï E. Cumulative pregnancy rate after ICSI-IVF in patients with colorectal endometriosis: results of a multicentre study. Hum Reprod 2012; 27:1043-1049.
3. Brosens JJ, de Souza NM, Barker FG, Paraschos T, Winston RM. Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics. Br J Obstet Gynaecol 1995; 102:471-474.
4. Camargo F, Gaytan J, Caligara C, Simon C, Pellicer A, Remohi J. Impact of ultrasound diagnosis of adenomyosis on recipients of sibling oocytes. Fertil Steril 2001;76:S150.
5. Costello M, Lindsay K, McNally G. The effect of adenomyosis on in vitro fertilisation and intra-cytoplasmic sperm injection treatment outcome. Eur J Obstet Gynaecol Reprod Biol 2011;158:229-234.
6. Ferenczy A. Pathophysiology of adenomyosis. Hum Reprod Update 1998; 4:312-322.
7. Gardner DK, Schoolcraft WB. Vitro culture of the human blastocyst. In: Jansen R, Mortimer D (eds). Towards Reproductive Certainty: Infertility and Genetics Beyond 1999.Carnforth, UK: Parthenon Publishing, 1999, 378-388.
8. Khan KN, Kitajima M, Hiraki K, Fujishita A, Sekine I, Ishimaru T, Masuzaki H. Changes in tissue inflammation, angiogenesis and apoptosis in endometriosis, adenomyosis and uterine myoma after GnRH agonist therapy. Hum Reprod 2010;25:642-653.
9. Kunz G, Beil D, Huppert P, Noe M, Kissler S, Leyendecker G. Adenomyosis in endometriosis-prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 2005;20:2309-2316.
10. Kunz G, Herbertz M, Biel D, Huppert P, Leyendecker G. Adenomyosis as a disorder of the early and late human reproductive period. Reprod Biomed Online 2007;15:681-685.
11. Larsen SB, Lundorf E, Forman A, Dueholm M. Adenomyosis and junctional zone changes in patients with endometriosis. Eur J Obstet Gynecol Reprod Biol 2011;157:206-211.
12. Maheshwari A, Gurunath S, Fatima F, Bhattacharya S. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod 2012;18:374-392.
13. Martinez-Conejero J, Morgan M, Monstesinos M, Fortuño S, Meseguer M, Simón C, Horcajadas JA, Pellicer A. Adenomyosis does not affect implantation, but is associated with miscarriage in patients undergoing oocyte donation. Fertil Steril 2011;96:943-950.
14. Maubon A, Faury A, Kapella M, Pouquet M, Piver P. Uterine junctional zone at magnetic resonance imaging: a predictor of in vitro fertilization implantation failure. J Obstet Gynaecol Res 2010;36:611-618.
15. Meredith SM, Sanchez-Ramos L, Kaunitz AM. Diagnostic accuracy of transvaginal sonography for the diagnosis of adenomyosis: systematic review and metaanalysis. AM J Obstet Gynecol 2009;201:107.e1-107.e6.
16. Mijatovic V, Florijn E, Halim N, Schats R, Hompes P. Adenomyosis has no adverse effects on IVF/ICSI outcomes in women with endometriosis treated with long term pituitary down regulation before IVF/ICSI. Eur J Obstet Gynecol Reprod Biol 2010;151:62-65.
17. Piver P. Uterine factors limiting ART coverage. J Gynecol Obstet Biol Reprod (Paris) 2005;34:5S30-5S33.
18. Shimizu Y, Fukuda J, Kawamura K, Tanaka T. Retrospectively analysis of the fertility of adenomyosis and the outcome of adenomyosis complicated pregnancy in in vitro fetrilization patients. Fertil Steril 2002;77:S50.
19. Tan BK, Vandekerckhove P, Kennedy R, Keay SD. Investigation and current management of recurrent IVF treatment failure in the UK. BJOG 2005;112:773-780.
20. Templeman C, Marshall SF, Ursin G, Horn-Ross PL, Clarke CA, Allen M, Deapen D, Ziogas A, Reynolds P, Cress R et al. Adenomyosis and endometriosis in the California teachers study. Fertil Steril 2008; 90:415-424.
21. Tremellen KP, Lane M. Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes. Hum Reprod 2010;25:1219-1224.
22. Tremellen K, Russell P. Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment. Aust N Z J Obstet Gynaecol 2011;51:280-283.
23. Tremellen KP, Russell P. The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: adenomyosis and macrophages. J Reprod Immunol 2012;93:58-63.
24. Valentini AL, Speca S, Gui B, Soglia G, Micco M, Bonomo L. Adenomyosis: from the sign to the diagnosis. Imaging, diagnostic pitfalls and differential diagnosis: a pictorial review. Radiol Med 2011; 116:1267-1287.
25. Verberg MF, Eijkemans MJ, Heijnen EM, Broekmans FJ, de Klerk C, Fauser BC, Macklon NS. Why do couples drop-out from IVF treatment? A prospective cohort study. Hum Reprod. 2008;23:2050-2055.
26. Yang JH, Chen MJ, Chen HF, Lee TH, Ho HN, Yang YS. Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis. Hum Reprod. 2004;19:1974-1978.
27. Youm HS, Choi YS, Han HD. In vitro fertilization and embryo transfer outcomes in relation to myometrial thickness. J Assist Reprod Genet 2011;28:1135-1140.